Arthritis, Psoriatic
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Genetic variation at the glycosaminoglycan metabolism pathway contributes to the risk of psoriatic arthritis but not psoriasis.
|
30552173 |
2019 |
Red Blood Cell Count measurement
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
Red cell distribution width determination
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
Finding of Mean Corpuscular Hemoglobin
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
RDW - Red blood cell distribution width result
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
Amino acids measurement
|
0.100 |
GeneticVariation
|
group |
GWASCAT |
Genome-wide study for circulating metabolites identifies 62 loci and reveals novel systemic effects of LPA.
|
27005778 |
2016 |
Protein measurement
|
0.100 |
GeneticVariation
|
group |
GWASCAT |
Genome-wide study for circulating metabolites identifies 62 loci and reveals novel systemic effects of LPA.
|
27005778 |
2016 |
Mean Corpuscular Volume (result)
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
The Allelic Landscape of Human Blood Cell Trait Variation and Links to Common Complex Disease.
|
27863252 |
2016 |
Finding of Mean Corpuscular Hemoglobin
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
The Allelic Landscape of Human Blood Cell Trait Variation and Links to Common Complex Disease.
|
27863252 |
2016 |
Amino acids measurement
|
0.100 |
GeneticVariation
|
group |
GWASCAT |
Genome-wide association study identifies novel genetic variants contributing to variation in blood metabolite levels.
|
26068415 |
2015 |
Serum albumin measurement
|
0.100 |
GeneticVariation
|
phenotype |
GWASDB |
Genome-wide association study identifies multiple loci influencing human serum metabolite levels.
|
22286219 |
2012 |
Neoplasms
|
0.020 |
Biomarker
|
group |
BEFREE |
The RNA expression of PAX5 was evaluated with reverse transcriptase polymerase chain reaction in the tumor tissue of 75 patients with stage TaT1 bladder cancer treated with transurethral resection.
|
16566978 |
2006 |
Neoplasms
|
0.020 |
AlteredExpression
|
group |
BEFREE |
Expression of tumor-associated trypsinogens (TAT-1 and TAT-2) in prostate cancer.
|
15651064 |
2005 |
Hypothyroidism
|
0.010 |
Biomarker
|
disease |
BEFREE |
Low T4 was observed in preterm infants irrespective of the cause of preterm birth, while maternal (TSH) and placental (DiO2, DiO3, and MCT10) compensatory responses were only activated in indicated preterm birth due to vascular complications.
|
29557697 |
2019 |
Cataract
|
0.010 |
Biomarker
|
disease |
BEFREE |
Interestingly, the absence of LAT2 led to increased incidence of cataract in mice, in particular in older females, and a synergistic effect was observed with simultaneous lack of TAT1.
|
31231240 |
2019 |
Carcinoma of urinary bladder, invasive
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 Update.
|
31443960 |
2019 |
Mental Depression
|
0.010 |
Biomarker
|
disease |
BEFREE |
Thirty-nine patients with depression were randomly assigned to immediate MCT (10 sessions) or a 10-week wait list period (WL).
|
28174547 |
2017 |
Depressive disorder
|
0.010 |
Biomarker
|
disease |
BEFREE |
Thirty-nine patients with depression were randomly assigned to immediate MCT (10 sessions) or a 10-week wait list period (WL).
|
28174547 |
2017 |
Euthyroid Sick Syndromes
|
0.010 |
Biomarker
|
disease |
BEFREE |
Herein, we aimed to evaluate the central and peripheral expression of genes involved in the transport (MCT8/<i>Slc16a2</i> and MCT10/<i>Slc16a10</i>), metabolism (<i>Dio1, Dio2</i>, and <i>Dio3</i>) and action (<i>Thra</i> and <i>Thrb</i>) of TH during NTIS induced by fasting or sepsis.
|
29118715 |
2017 |
Septicemia
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
CLP induced sepsis resulted in reduced: (1) T<sub>4</sub> serum levels; (2) <i>Dio1, Slc16a2, Slc16a10, Thra</i>, and <i>Thrb</i> expression in liver as well as <i>Slc16a2</i> expression in the thyroid gland (3) <i>Thrb</i> and <i>Tshb</i> mRNA expression in the pituitary; (4) total leukocyte counts in the bone marrow while increased its number in peritoneal and pleural fluids.
|
29118715 |
2017 |
Sepsis
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
CLP induced sepsis resulted in reduced: (1) T<sub>4</sub> serum levels; (2) <i>Dio1, Slc16a2, Slc16a10, Thra</i>, and <i>Thrb</i> expression in liver as well as <i>Slc16a2</i> expression in the thyroid gland (3) <i>Thrb</i> and <i>Tshb</i> mRNA expression in the pituitary; (4) total leukocyte counts in the bone marrow while increased its number in peritoneal and pleural fluids.
|
29118715 |
2017 |
Depressed mood
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
Thirty-nine patients with depression were randomly assigned to immediate MCT (10 sessions) or a 10-week wait list period (WL).
|
28174547 |
2017 |
Malignant neoplasm of urinary bladder
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Focusing on patients with TaT1 non-muscle invasive BCa, BCL2L12 expression levels were correlated with higher recurrence rate at the first follow-up cystoscopy and were unveiled to be an independent unfavorable predictor of patients' short-term recurrence following transurethral resection.
|
23790536 |
2014 |
Bladder Neoplasm
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Focusing on patients with TaT1 non-muscle invasive BCa, BCL2L12 expression levels were correlated with higher recurrence rate at the first follow-up cystoscopy and were unveiled to be an independent unfavorable predictor of patients' short-term recurrence following transurethral resection.
|
23790536 |
2014 |
Drug habituation
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
Tat1-86 induced developmental neurotoxic effects, as witnessed by delays in eye opening, delays in early reflex development and alterations in prepulse inhibition (PPI) and between-session habituation of locomotor activity.
|
25285887 |
2014 |